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Abstract
Background: The main aims of this paper are to describe the setting and design of a Minimal
Intervention in general practice for Stress-related mental disorders in patients on Sick leave (MISS),
as well as to ascertain the study complies with the requirements for a cluster randomised
controlled trial (RCT). The potential adverse consequences of sick leave due to Stress-related
Mental Disorders (SMDs) are extensive, but often not recognised. Since most people having SMDs
with sick leave consult their general practitioner (GP) at an early stage, a tailored intervention given
by GPs is justified. We provide a detailed description of the MISS; that is more accurate assessment,
education, advice and monitoring to treat SMDs in patients on sick leave. Our hypothesis is that
the MISS will be more effective compared to the usual care, in reducing days of sick leave of these
patients.
Methods: The design is a pragmatic RCT. Randomisation is at the level of GPs. They received the
MISS-training versus no training, in order to compare the MISS vs. usual care at patient level.
Enrolment of patients took place after screening in the source population, that comprised 20–60
year old primary care attendees. Inclusion criteria were: moderately elevated distress levels, having
a paid job and sick leave for no longer than three months. There is a one year follow up. The
primary outcome measure is lasting full return to work. Reduction of SMD- symptoms is one of
the secondary outcome measures. Forty-six GPs and 433 patients agreed to participate.
Discussion: In our study design, attention is given to the practical application of the requirements
for a pragmatic trial. The results of this cluster RCT will add to the evidence about treatment
options in general practice for SMDs in patients on sick leave, and might contribute to a new and
appropriate guideline. These results will be available at the end of 2006.
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Background
Stress-related mental disorders (SMDs)
Stress results from an imbalance between demands and
resources [1]. It is a psychological, physiological and
behavioural response by individuals when they perceive a
lack of equilibrium between the demands placed upon
them and their ability to meet those demands. This
response, over a period of time, leads to ill-health [2] and
it is important to respect the roles of personal, social, eco-
nomic, occupational and physical health problems in
determining and shaping this psychological disability [3].
Fatigue, tenseness, irritability, apathy, sleeping disorder,
emotional instability, rumination and concentration-
problems are examples of common symptoms related to
stress and a failure to cope with demands while resources
(i.e. the abilities to meet those demands) are not suffi-
cient. In addition, some patients with persistent distress
go on to develop a psychiatric disorder, notably major
depression or anxiety disorder, based on specific vulnera-
bilities. Plus, persistent distress may give rise to somatic
complaints and subsequent somatization [4]. It is clear
and evidence- based to treat major psychiatric disorders
with medication or counselling, whereas evidence- based
interventions for the whole range of Stress-related Mental
Disorders (SMDs) are still under development.
SMDs and sick leave
The societal and financial costs of dysfunction in terms of
(long term) sick leave due to SMDs are extensive. In the
Netherlands, almost one million workers are entitled to
disability benefits (9 percent of the working population),
this prevalence is high compared with other countries [5].
About one third of the 9.407 billion Euros in 2004 of the
disability benefits in the Netherlands was paid to persons
with mental health problems [6]. Whereas only ten per-
cent of those receiving disability benefits have an actual
psychiatric disorder, ninety percent is due to what patients
and care-providers consider to be SMDs [7]. Furthermore,
the composition of the group of workers who receive dis-
ability benefit in the Netherlands is changing disquiet-
ingly: currently young female employees, mostly with
mental health problems, constitute the majority of new
cases [8]. Chronicity of SMDs with sick leave is growing,
although several studies indicate that SMDs can be treated
successfully if they are diagnosed and treated at an early
stage[9]. However, for a long time the usual approach to
SMDs with sick leave was the reverse: advice to take rest
and not return to work before all complaints had disap-
peared. Last but not least, patients with SMDs being on
sick leave definitely cannot be reduced to only an eco-
nomic problem; of course much personal suffering is
involved. Moreover, the value of work is undisputed and
in cases of (prolonged) sick leave there is a risk of perma-
nent loss of employment.
General Practice treatment of SMDs in patients on sick 
leave
Nearly every employee contacts the GP at the beginning of
the sick leave. Most patients having SMDs are managed in
primary care, and not referred to specialised secondary
care. And despite the fact that mental health problems are
common in primary care, GP's may still find it difficult to
diagnose and treat them, unless they have a high index of
suspicion [10]. Due to the collaborative nature of the doc-
tor-patient relationship in general practice, many GPs
may be overly cautious to attribute symptoms to a psycho-
social cause. Another issue is an adequate differential
diagnosis; many patients in primary care have symptoms
related to anxiety, depression, somatization, or all three.
In one out of five patients having a SMD there are promi-
nent, although unrecognised symptoms of depression or
anxiety, which are associated with a poor prognosis. A fur-
ther pitfall is that GPs often tend to go along with the
patient's request for rest and being left alone. Often GPs
advise to go or stay on sick leave, to take rest, seek distrac-
tion and relaxation, instead of actively confront and cope
with the difficulties. The distress of a lasting crisis com-
bined with existing vulnerabilities may lead to prolonged
disability and contribute to the development of serious
mental disorders, e.g. depression or anxiety disorders. Ear-
lier research revealed that about 20% of patients having a
SMD stayed on sick leave for more than a whole year [11].
Cooperation between GPs and the occupational health
care system seems to be in the best interest of all involved
and also the preferred way to manage SMDs with sick
leave.
The Minimal Intervention for Stress-related mental 
disorders with Sick leave (MISS)
Terluin and Van der Klink [12] have outlined an activating
intervention for patients having a SMD with sick leave,
that already proved to be effective in reducing sick leave
by 30% in an occupational health care setting [13]. Taken
into account that GPs only have limited time during con-
sulting hours, we developed the Minimal Intervention for
Stress-related mental disorders with Sick leave (MISS) for
general practice. In the MISS the principle of time contin-
gency is used. Also, parts of more specialised psychologi-
cal treatments like Cognitive Behavioural Therapy
(CBT[14]) and Problem Solving Treatment (PST [15,16])
are incorporated. With respect to the role of gatekeeper in
primary care practice, only basic principles of CBT and
PST were considered relevant for GPs [17].
The MISS is a prototypical intervention for SMDs with sick
leave in general practices, aiming specifically at successful
rehabilitation and preventing long-lasting sick leave. By
using specific communication and the minimal amount
of time necessary, the GP helps the patient on the accurate
and time-contingent course. The MISS should take noBMC Public Health 2006, 6:124 http://www.biomedcentral.com/1471-2458/6/124
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more than 3 consultations of 10–20 minutes, and consists
basically of 5 elements: assessment, education, advice,
monitoring and, if necessary, referral.
Assessment implies in the first place to identify patients
having a SMD and help them to acknowledge their dis-
tress. Second, the GP detects significant depression and
anxiety, and propose management steps for these prob-
lems separately. The Four-Dimensional Symptom Ques-
tionnaire (4DSQ, [18]) is used in the MISS to quantify the
level of distress, and to detect symptoms of depression
and anxiety. Guidelines from the Dutch College of Gen-
eral Practitioners are available to support the diagnosis
and treatment of possible depression and anxiety disor-
ders [19,20]. When physical illness has not yet been ruled
out, the patient may have some somatic diagnostic exam-
inations done, next to filling in the 4DSQ.
Education aims at promoting the patient's understanding
and acceptance of the cause of the breakdown. Informa-
tion is given on the normal course after having a SMD
with sick leave, in this the patient's own active role is
emphasised. The GP also gives information about the role
and function of the occupational physician in the health
care system. When the diagnosis may not yet be definitive,
although the suspicion of a SMD is present, the education
is still provided in the first consultation in order not to
lose precious time.
Advice is given on coping with the breakdown, making a
start with solving the problems, and planning to gradually
take up social functioning. The GP underlines the impor-
tance of a balance in taking rest and making an active
approach towards the problems, like using a rumination
session (that is writing down what specifically troubles
the patient) one or two times a day for 30–45 minutes.
The patient is also advised to schedule necessary activities
of daily living, such as children's care and housekeeping.
Furthermore the patient is recommended to visit his or
her occupational physician without delay, and to explore
ways after which it is possible to partially return to work,
even when not all symptoms have disappeared.
Monitoring is about ensuring the patient is moving
towards the accurate course. This implies a focus on the
problems (and possible solutions) in stead of symptoms.
The patient has to investigate the specific problems and
consider different ways to cope. The switch in the patient's
focus has often already occurred before the second consul-
tation; however it should in any case have occurred after
four weeks of sick leave.
Referral to specialised care comes into play when there is
no evidence of progression after four weeks of sick leave.
The GP should realize that the patient is at risk for pro-
longed sick leave and ultimately loss of employment. A
more specialised treatment is necessary since the patient is
not likely to benefit from more time off. The GP may refer
the patient to a counsellor, social worker or a (cognitive
behavioural) psychotherapist, ideally after consulting
with the occupational physician.
Methods
Objective
The central aim of this pragmatic cluster randomised con-
trolled trial (RCT) is to investigate the effectiveness of the
MISS in general practice. Our hypothesis is that GPs who
carry out the MISS will be more effective than GPs who
perform usual care in reducing the number of days of sick
leave, as well as in reducing symptoms of SMDs in
patients. Usual care in general practice contains the guide-
lines on depression [19] and anxiety [20]. In the case of
the MISS, GPs are trained in topic- specific knowledge on
patients with SMDs on sick leave. Because GPs, who have
learned to apply the MISS, cannot be expected to perform
this intervention in some patients and treat others as they
used to do prior to the training, randomisation at the level
of individual patients was not feasible. To avoid possible
contamination between the conditions, a cluster design
randomising at the level of GPs was chosen. There will be
a one year follow up on the patients to assess the outcome
measures and factors involved in the process of sick leave
and return to work. The study design, protocol and proce-
dures were approved by the Medical Ethics Committee of
the VU University Medical Centre.
Participants
GPs
The recruitment of GPs was split up in four different
rounds. We approached GPs in two different districts
where the Department of General Practice of the VU Uni-
versity Medical Centre has some type of network posi-
tioned. A total of 46 GPs signed informed consent.
Patients
In order to recruit enough eligible patients, we made use
of the computerised patient record system and
approached the source population of patients (n =
22.740) by mail. The source population consisted of all
primary care attendees (20–60 years) who visited consult-
ing hours of the participating GPs. GP's excluded only
patients with very severe psychiatric disorders (mania or
psychosis), patients with terminal illness or an inadequate
command of the Dutch language. The source population
of attendees was asked only to respond when they met our
criteria: moderately elevated distress level (measured with
3 questions of the 4DSQ distress scale, [18]), having paid
work and being (partially) on sick leave for no longer than
three months (see table 1).BMC Public Health 2006, 6:124 http://www.biomedcentral.com/1471-2458/6/124
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Every one or two weeks we approached the source popu-
lation, until enrolment of a sufficient number of patients
from a particular GP was realised. Final recruitment took
place by phone survey of the patients who returned the
questionnaire and met the criteria. A total of 433 patients
(1,9%) who could and also wanted to participate were
enrolled (see figure 1). The overall response percentage on
our screening method was 51.5%, this was measured in a
group of 336 randomly selected attendees. This labour-
intensive however highly successful method of screening
ensures that we recruited patients having SMDs with sick
leave in stead of patients who actually get an intervention
for their complaints.
Intervention at the level of general practitioners
In order to use the intervention, additional training in the
MISS was given to intervention GPs by one of the authors
(BT), and an occupational physician. This training existed
of two times 3,5 hours and 2 times follow-up of 2 hours
(total of 11 hours). Skills needed for successful treatment
were accentuated. The participating GPs own experiences
were evaluated; they were expected to provide case histo-
ries and to practice with the different parts of the interven-
tion during the training. Screening of eligible patients
started after the MISS group got the second training. When
a patient had signed the informed consent (about four
weeks after oral informed consent in the telephonic base-
line measure), the GP was informed of the participation.
Actual application of the elements of the MISS and steps
in usual care are measured with a questionnaire.
Intervention at the level of the patients
During the baseline interview all patients were asked
whether they had planned another visit to their GP. If not
they were advised to consider this, in order to give the GPs
the opportunity to start with an intervention. Even
though, it should be noted that neither the GPs were
obliged to apply the MISS or any other intervention for
mental disorders, nor were the patients obliged to go visit
their GPs. No intervention was done on the actual com-
pletion or successfulness of the application of the MISS,
the present method comprises real clinical practice in pri-
mary care.
Outcome measures
Sick leave
The primary outcome measure is defined as: duration of
sick leave in calendar days from the first day of sick leave
to full return to work, lasting at least 4 weeks without (par-
tial or full) relapse. Variables of the rehabilitation process
itself, like the time to first (partial or full) return to work,
total days of sick leave in the whole year, and (partial or
full) return to work rates after 2, 6 and 12 months, are sec-
ondary outcome measures. Sick leave in the past year is
considered to be a prognostic factor for our primary out-
come measure, as are job content data [21,22].
Reduction of SMD symptoms
An important secondary outcome measure is reduction in
symptoms of depression, anxiety, somatization and dis-
tress, measured with the 4DSQ [18]. Life-events and prob-
lems, chronic illnesses and neuroticism [23] are
prognostic measures for this outcome. Problem evalua-
tion [24] and coping styles [25] are measured to evaluate
the effective components of the MISS: problem- and solu-
tion focus skills of patients.
Economic evaluation
Cost effectiveness will be evaluated from societal perspec-
tive (that is, irrespective of who is paying for the costs to
gain an effect) by using the Tic-P [26]. The employers per-
spective (expenditures for the employer) is represented by
the HPQ [27,28]. The EuroQol [29] measures general
health state, and as a result quality of life status, that can
be compared with a wide range of conditions in health
care.
Data collection
At baseline, patients who entered the study were meas-
ured by a phone survey and received a questionnaire by
mail. Follow-up measurements, again a phone survey fol-
lowed by a questionnaire, were scheduled at 2, 6 and 12
Table 1: Eligibility criteria
No Sometimes Regularly or often
1. During the past week, did you suffer from worry? 0 1 2
2. During the past week, did you suffer from listlessness? 0 1 2
3. During the past week, did you feel tense? 0 1 2
4. Total score 4 or higher?  Yes  No
5. Do you currently have a paid job?  Yes  No
6. Are you currently on sick leave for a period no longer than three months?  Yes  No
People were asked only to send in the questionnaire when they scored three times 'yes' and were willing to participate.BMC Public Health 2006, 6:124 http://www.biomedcentral.com/1471-2458/6/124
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'Flow chart' Figure 1
'Flow chart'.
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months after baseline. All outcomes were measured at the
level of the patient, except for the GP interventions and
skills. These were reported by the GPs two months after
baseline. Moreover, data on received health care were
extracted from the medical records after the completion of
the one year follow-up.
Power & sample size
Proportions used to determine the sample size needed,
were adopted from a related study completed in the occu-
pational health care setting [13]. In that study, after a
period of 3 months 79% in the intervention group versus
64% in the control group had fully returned to work. In
order to detect a relevant difference in survival analysis on
our primary outcome measure, nQuery Advisor [30] was
used to calculate the sample size. With a power of 80% at
a 0.05 level two-sided log-rank test for equality of survival
curves between the MISS group proportion still on sick
leave of 0.21 and a usual care group proportion of 0.36 at
the given time of 3 months, the sample size needed in
each group was 126 (with a constant hazard ratio of
1.528). Taking into account an intracluster correlation
coefficient (ICC) of .025 (clustering effect in our groups is
not presumed to be large) for randomisation at GP level
and 7 patients per cluster (GP), a total of 290 patients are
needed. Assuming a dropout rate of 30% (approximately
10% at each follow up), inclusion of a total of 415
patients is necessary.
Randomisation
Randomisation took place at the level of GPs, after each of
the four recruitment moments and after the GPs signed
informed consent. Because balance between groups in
size and characteristics was presumed all four times GPs
were randomised, no blocking or stratification was used.
We developed the following procedure to conceal alloca-
tion. The names of the GP's (and dummy in an uneven
group) were put on a list of which the order was subse-
quently randomised by one person (IMB). Another per-
son (BT) independently drew up a randomised list of
codes (1 = MISS group and 2 = control group) with an
equal number of '1' and '2' codes up to the number of GPs
Table 2: Outcome measures
Baseline Follow up in months
Outcome measure Instrument 0 2 6 12
Primary outcome (dependent)
Lasting return to work: duration of sick leave in calendar days 
from the first day of sick leave to full return to work, for at 
least 4 weeks without (partial or full) relapse
Patients report X X X X
Secondary outcomes (dependent)
Time to first (full or partial) return to work Patients report X X X X
Return to work rates Patients report X X X X
Total days of sick leave during one year follow up Patients report X X X X
Recurrence of sick leave Patients report X X X X
Reduction of symptoms 4DSQ [18,31] X X X X
Health state profile Euroqol [29] X X X X
Costs of health care and loss of productivity Tic-P [26] X X X X
Absenteeism, quality and quantity of work HPQ [27,28] X X
Problem evaluation Psychlops (MYMOP) [24,33] X X X X
Coping processes Ways of Coping 
Questionnaire [25]
XXXX
Patient satisfaction Patients report X X X
Application of the MISS: number of visits, diagnosis, advice & 
treatment, proceeding of recovery process over the past year
Medical record & 
questionnaire filled in by GP
X
Prognostic measures (independent predictor or 
covariate)
Mental disorders PRIME-MD [32,34] X
Sick leave in year before Patients report X
Problems, life events, chronic illnesses Patients report X X X
Work experience/burn out UBOS [21] X X
Job content data, job stress JCQ [22] X
Critical incidents HPQ [27] X X
Neuroticism NEO-FFI [23] XBMC Public Health 2006, 6:124 http://www.biomedcentral.com/1471-2458/6/124
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being randomised. Finally, these two lists were brought
together and the first GP on the list was allocated to the
group indicated by the first code; and so on. As a result, 24
GPs were allocated to the intervention (MISS) group and
22 GPs were allocated to the control (usual care) group.
Implementation
After assigning the GPs and training was given to the MISS
group, patients were enrolled by screening the source pop-
ulation (see participants). The general practice team gave
entrance to data on the source population, the source
population was given the inclusion criteria through a
screening questionnaire. The research assistance team was
responsible for the final recruitment. They gave informa-
tion in a phone survey and asked the patient informed
consent to participate.
Blinding
Patients were kept unaware that two different interven-
tions were studied; both groups were given exactly the
same information and questionnaires. The patients, as
well as the external interviewers who carried out the
phone surveys, were told that the study was about stress
and sick leave. Finally, the internal research assistance
team responsible for the process of data collection knew
that the study involved a training of half of the GPs; nev-
ertheless the internal research team had no information
on which GPs were allocated to what conditions.
Statistical methods
First of all, baseline similarity between the MISS and usual
care groups will be examined, and baseline characteristics
of drop outs and completers will be compared. Cox regres-
sion analyses will be used to investigate the intervention
effect, by analysing differences in outcome with survival
analysis of the primary outcome measure between the
MISS and usual care group. To correct for misclassification
of patients and severity of complaints (inclusion is only
by level of distress with sick leave), and as a consequence
to avoid bias in the effect, baseline measures of psycholog-
ical symptoms (by means of the 4DSQ [31] & PRIME-MD
[32]), as well as medical records will be examined. Addi-
tionally, subgroup analysis can be done by level of sever-
ity of complaints.
Linear and logistic multilevel analyses will be used to
investigate the intervention effect on all secondary out-
come measures: rates of return to work, psychological
symptoms, problem experience and coping style. Also,
longitudinal multivariate analysis will be used to examine
differences in improvement in all secondary outcome
measures between the treatment groups. Analysis will be
performed on an intention-to-treat basis and intra-class-
correlation will be calculated to correct for possible clus-
tering of observations. Levels included will be: repeated
measures, patients and GPs. Subgroups for analysis will
be modelled by the prognostic factors mentioned.
Costs will be measured and valued from a societal per-
spective. Mean direct and indirect medical costs (meas-
ured with the Tic-P[26]), costs of productivity loss due to
sick leave (measured with the WHO HPQ[28]) and total
costs will be compared between both groups. Confidence
intervals around mean differences will be estimated with
bootstrapping methods. With regard tot the primary out-
come, sick leave, a cost benefit analysis will be performed,
in which costs of productivity loss due to sick leave will be
compared with direct en indirect medical costs.
A cost-effectiveness analysis will be performed to assess
the incremental costs per unit improvement on the 4DSQ
[18]. Bootstrapping methods will be used to estimate the
confidence interval for the cost-effectiveness ratio and to a
draw cost-effectiveness plane. Similarly, utility assessed
with the EuroQol [29] will be used to estimates the incre-
mental costs per Qualy gained in a cost-utility analysis.
As regards the prognostic measures, univariate analyses
will be used to select relevant factors, with a focus on iden-
tifying prognostic factors for our primary outcome meas-
ure. Subsequently, Cox regression analyses and logistic
regression analysis will be performed on these relevant
factors.
Discussion
SMDs in primary care
This project is developed for the primary care setting with
its' typical case load of stress-related mental disorders, and
not for specialised care in which patients have more
clearly defined mental disorders. We provide an interven-
tion that is aimed at better recognition, good communica-
tion, and a time-contingent framed recovery process. Our
approach of SMDs, with the need to identify specific psy-
chiatric disorders where they exist and also to respect the
roles of daily life in determining and shaping psychologi-
cal disability, is an example of specified stepped care in
general practice. Potential risk factors for chronicity are
pointed out in our training, and early recognition and
treatment is the main goal of the MISS. The role of more
specialised care is well acknowledged in the intervention.
Benefits of our screening method
Particular strength of our study protocol is the method of
recruiting patients. By using the computerised patient
record system, we screened the whole population of gen-
eral practice attendees and thereby determined who
entered the study, instead of chartering the GPs to select
their patients. Therefore, similarity in both groups is
assured and we avoided selection bias. Also, we did not
have difficulties in including enough eligible patients,BMC Public Health 2006, 6:124 http://www.biomedcentral.com/1471-2458/6/124
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which is often a problem in primary care trials. Further-
more, the current method allows us to consider the prag-
matic effectiveness and to avoid interference with daily
practice of consulting hours. In this trial, follow-up is on
patients having SMDs with sick leave, instead of patients
who actually get an intervention for their complaints.
Good external validity (i.e. generalizability) is accom-
plished by this rather heterogeneous, and therefore highly
representative, group of patients with SMDs on sick leave.
To assure as much internal validity as possible in this
pragmatic trial, we randomised on the level of GPs to
avoid contamination. In addition, research assistants who
collected the data and also the patients were blinded.
Prospect on outcomes
Notably, effectiveness instead of efficacy is studied. We are
evaluating what is possible in real clinical practice, rather
than under ideal circumstances. As a consequence, mental
health state will vary between the participants. Through
subgroup analysis on severity of complaints and levels of
distress (measured with the PRIME-MD and 4DSQ), we
can classify possible high or low risk groups for prolonged
disability within this heterogeneous group. Identification
of a high risk group for non-recovery may lead to better
suited guidelines on stepped care and treatment. We can-
not assure that everyone in the MISS group has received
the intervention; the GPs were given total freedom in actu-
ally delivering the MISS. Nevertheless, the number of vis-
its, diagnoses, recommendations, treatments and
proceedings will give us information about the compli-
ance of the GPs and their influence on the effect of the
MISS. In this way, daily practice is measured in stead of
ideal circumstances. To avoid social desirable answers
from the GPs on their advises and treatments, we will also
check the medical records of the patients.
Finally, many requirements for a high quality trial are
being met. Results of this cluster RCT will contribute to
treatment options for patients having SMDs with sick
leave in general practice, and might contribute to new and
better suited guidelines and stepped care. Results will be
available in the end of 2006.
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